CVS Health Corp (CVS)
79.36
-0.49 (-0.61%)
NYSE · Last Trade: Dec 31st, 5:15 PM EST
Detailed Quote
| Previous Close | 79.85 |
|---|---|
| Open | 79.79 |
| Bid | 79.28 |
| Ask | 79.78 |
| Day's Range | 79.32 - 79.85 |
| 52 Week Range | 43.65 - 85.15 |
| Volume | 3,107,612 |
| Market Cap | 104.72B |
| PE Ratio (TTM) | 203.49 |
| EPS (TTM) | 0.4 |
| Dividend & Yield | 2.660 (3.35%) |
| 1 Month Average Volume | 7,172,096 |
Chart
About CVS Health Corp (CVS)
CVS Health Corp is a diversified healthcare company that operates a vast network of retail pharmacies, providing prescription medications, over-the-counter products, and health and wellness services. In addition to its retail operations, CVS Health also offers pharmacy benefit management services, helping manage prescription drug costs for businesses and health plans. The company is involved in providing health insurance and health services through its various divisions, including a growing presence in digital health solutions and immunization services. By integrating pharmacy services with healthcare delivery, CVS Health aims to enhance patient care and improve health outcomes across the communities it serves. Read More
News & Press Releases
The long-standing dominance of Pharmacy Benefit Managers (PBMs) in the American healthcare system has reached a critical inflection point as 2025 draws to a close. For decades, these "middlemen" operated in the shadows, negotiating drug prices and rebates with manufacturers while managing prescription benefits for millions. However, a relentless wave
Via MarketMinute · December 31, 2025
As the curtain closes on 2025, the investment community is witnessing a significant shift in sentiment regarding the managed care sector. Cigna Group (NYSE: CI) has become the centerpiece of this narrative, receiving a wave of analyst upgrades to ‘Buy’ in the final weeks of December. Market experts are increasingly
Via MarketMinute · December 31, 2025
Both ETFs target short-term investment-grade bonds, but their construction determines how visible credit risk becomes when spreads move.
Via The Motley Fool · December 30, 2025
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Via StockStory · December 28, 2025
Both funds invest in investment-grade corporate bonds, but they sit in very different places on the yield curve. Over time, that distinction determines how each fund moves when interest rates shift
Via The Motley Fool · December 26, 2025
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Via StockStory · December 23, 2025
Both ETFs hold investment-grade corporate bonds, but LQD prioritizes balance while VCLT ties returns more closely to long-term rate moves
Via The Motley Fool · December 22, 2025
The stocks listed here trade at forward earnings multiples of less than 18.
Via The Motley Fool · December 18, 2025
The healthcare sector is a great place to find quality income stocks, and these two appear to be strong picks.
Via The Motley Fool · December 18, 2025
Health insurance stocks split after a House GOP revolt revived debate over ACA subsidies, while a year-end extension was ruled out.
Via Stocktwits · December 17, 2025
CVS Health Corp shows strong technical momentum and a perfect basing setup, signaling a potential breakout opportunity for chart-focused traders.
Via Chartmill · December 16, 2025
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately
as healthcare stocks have returned 14.6% over the past six months, topping the S&P 500 by 1.5 percentage points.
Via StockStory · December 15, 2025
Synergy CHC Corp. (NASDAQ: SNYR) is drawing renewed attention after Roth Capital Partners reaffirmed its Buy rating and issued a $7 price target, citing strong fundamentals, a growing product portfolio, and a new phase of revenue acceleration driven by the company’s expanding functional beverage business .
Via AB Newswire · December 11, 2025
LOS ANGELES, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national litigation firm, announces that it is investigating claims on behalf of policyholders of Aetna Medicare Advantage plans through CVS Health Corporation (“CVS”) for breach of contract and related violations of state laws.
By Schall Law · Via GlobeNewswire · December 10, 2025
Small-capitalization stocks are currently experiencing an unprecedented surge, with the benchmark Russell 2000 index shattering all-time records in early December 2025. This remarkable rally, which saw the index climb over 13% year-to-date, signifies a profound shift in investor sentiment and a significant rebalancing of capital away from the long-dominant technology
Via MarketMinute · December 11, 2025
CVS Health’s 22.1% return over the past six months has outpaced the S&P 500 by 8.7%, and its stock price has climbed to $78.44 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Via StockStory · December 9, 2025
UnitedHealth Group raised its dividend in each of the last 16 years.
Via The Motley Fool · December 9, 2025
Glenview Capital Management reduced its stake in Alight by roughly 16% during the third quarter.
Via The Motley Fool · December 9, 2025
Shares of diversified healthcare company CVS Health (NYSE:CVS)
jumped 3.2% in the morning session after the company raised its financial guidance for 2025 and provided a strong forecast for 2026 at its Investor Day event.
Via StockStory · December 9, 2025
Glenview Capital Management added to its massive position in Teva Pharmaceuticals stock.
Via The Motley Fool · December 9, 2025
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner.
Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Via StockStory · December 7, 2025
HCA Healthcare and CVS Health are firing on all cylinders.
Via The Motley Fool · December 4, 2025
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including CVS Health (NYSE:CVS) and its peers.
Via StockStory · December 3, 2025
Expense ratios, sector focus, and portfolio makeup set these two consumer staples ETFs apart for investors seeking the right fit.
Via The Motley Fool · December 1, 2025
Large-cap stocks usually command their industries because they have the scale to drive market trends.
The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
Via StockStory · December 1, 2025